Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Searching for the Source: Bacteremia with pleocytosis.

Chatterjee S, Baer AN, Kontzialis M, Aggarwal NR, Gelber AC.

Am J Med. 2015 Aug 21. pii: S0002-9343(15)00779-2. doi: 10.1016/j.amjmed.2015.08.005. [Epub ahead of print] No abstract available.

PMID:
26302143
2.

PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.

Fiorentino DF, Presby M, Baer AN, Petri M, Rieger KE, Soloski M, Rosen A, Mammen AL, Christopher-Stine L, Casciola-Rosen L.

Ann Rheum Dis. 2015 Aug 7. pii: annrheumdis-2015-207509. doi: 10.1136/annrheumdis-2015-207509. [Epub ahead of print]

PMID:
26253095
3.

Physical function, hyperuricemia and gout in older adults enrolled in the atherosclerosis risk in communities cohort study.

Burke BT, Köttgen A, Law A, Windham BG, Segev D, Baer AN, Coresh J, McAdams-DeMarco MA.

Arthritis Care Res (Hoboken). 2015 Jul 2. doi: 10.1002/acr.22648. [Epub ahead of print]

PMID:
26138016
4.

Ocular Complications of Primary Sjögren Syndrome in Men.

Mathews PM, Hahn S, Hessen M, Kim J, Grader-Beck T, Birnbaum J, Baer AN, Akpek EK.

Am J Ophthalmol. 2015 Sep;160(3):447-452.e1. doi: 10.1016/j.ajo.2015.06.004. Epub 2015 Jun 17.

PMID:
26093285
5.

Antibodies to interferon-inducible protein-16 in primary Sjögren's syndrome are associated with markers of more severe disease.

Baer AN, Petri M, Sohn J, Rosen A, Casciola-Rosen L.

Arthritis Care Res (Hoboken). 2015 Jun 2. doi: 10.1002/acr.22632. [Epub ahead of print]

PMID:
26037655
6.

Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome.

Hall JC, Baer AN, Shah AA, Criswell LA, Shiboski CH, Rosen A, Casciola-Rosen L.

Arthritis Rheumatol. 2015 Sep;67(9):2437-46. doi: 10.1002/art.39204.

PMID:
25988820
7.

The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome.

Baer AN, McAdams DeMarco M, Shiboski SC, Lam MY, Challacombe S, Daniels TE, Dong Y, Greenspan JS, Kirkham BW, Lanfranchi HE, Schiødt M, Srinivasan M, Umehara H, Vivino FB, Vollenweider CF, Zhao Y, Criswell LA, Shiboski CH; Sjögren's International Collaborative Clinical Alliance (SICCA) Research Groups; Sjögren's International Collaborative Clinical Alliance SICCA Research Groups.

Ann Rheum Dis. 2015 Aug;74(8):1557-61. doi: 10.1136/annrheumdis-2014-206683. Epub 2015 Mar 3.

PMID:
25735642
8.

Ocular and systemic morbidity in a longitudinal cohort of Sjögren's syndrome.

Akpek EK, Mathews P, Hahn S, Hessen M, Kim J, Grader-Beck T, Birnbaum J, Baer AN.

Ophthalmology. 2015 Jan;122(1):56-61. doi: 10.1016/j.ophtha.2014.07.026. Epub 2014 Aug 30.

PMID:
25178806
9.

Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study.

Maynard JW, McAdams-DeMarco MA, Law A, Kao L, Gelber AC, Coresh J, Baer AN.

Am J Epidemiol. 2014 Mar 1;179(5):576-83. doi: 10.1093/aje/kwt299. Epub 2013 Dec 13.

10.

Risk factors for incident hyperuricemia during mid-adulthood in African American and white men and women enrolled in the ARIC cohort study.

McAdams-DeMarco MA, Law A, Maynard JW, Coresh J, Baer AN.

BMC Musculoskelet Disord. 2013 Dec 11;14:347. doi: 10.1186/1471-2474-14-347.

11.

Constrictive pleuropericarditis: a dominant clinical manifestation in Whipple's disease.

Stojan G, Melia MT, Khandhar SJ, Illei P, Baer AN.

BMC Infect Dis. 2013 Dec 9;13:579. doi: 10.1186/1471-2334-13-579.

12.

Pulmonary manifestations of Sjögren's syndrome.

Stojan G, Baer AN, Danoff SK.

Curr Allergy Asthma Rep. 2013 Aug;13(4):354-60. Review.

13.

Noninflammatory myopathies.

Baer AN, Wortmann RL.

Rheum Dis Clin North Am. 2013 May;39(2):457-79. doi: 10.1016/j.rdc.2013.02.006. Epub 2013 Mar 16. Review.

PMID:
23597974
14.

Acroosteolysis in diabetes mellitus.

Baer AN, Zahr ZA, Khan S, Polydefkis M.

J Rheumatol. 2012 Dec;39(12):2364-5. doi: 10.3899/jrheum.120662. No abstract available.

PMID:
23204315
15.

Rare diagnosis of IgG4-related systemic disease by lip biopsy in an international Sjögren syndrome registry.

Baer AN, Gourin CG, Westra WH, Cox DP, Greenspan JS, Daniels TE; Sjögren's International Collaborative Alliance.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Mar;115(3):e34-9. doi: 10.1016/j.oooo.2012.07.485. Epub 2012 Nov 10.

16.

Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases.

Hall JC, Casciola-Rosen L, Berger AE, Kapsogeorgou EK, Cheadle C, Tzioufas AG, Baer AN, Rosen A.

Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17609-14. doi: 10.1073/pnas.1209724109. Epub 2012 Oct 8.

17.

Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort.

McAdams-DeMarco MA, Maynard JW, Baer AN, Coresh J.

J Clin Hypertens (Greenwich). 2012 Oct;14(10):675-9. doi: 10.1111/j.1751-7176.2012.00674.x. Epub 2012 Jun 13.

18.

Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study.

McAdams-DeMarco MA, Maynard JW, Coresh J, Baer AN.

Arthritis Res Ther. 2012 Aug 20;14(4):R193. doi: 10.1186/ar4026.

19.

Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management.

Stojan G, Baer AN.

Expert Rev Clin Immunol. 2012 Jul;8(5):439-53. doi: 10.1586/eci.12.36. Review.

PMID:
22882219
20.

Occult erosions in Jaccoud arthropathy.

Park JK, Carrino JA, Baer AN.

J Clin Rheumatol. 2012 Aug;18(5):277-8. doi: 10.1097/RHU.0b013e3182642355. No abstract available.

PMID:
22832301
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk